Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy
NCT00038571
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma, B-Cell
Interventions
DRUG:
PS341 (Bortezomib)
Sponsor
M.D. Anderson Cancer Center
Collaborators
[object Object]